Adam Mecca, MD, PhD

Adam Mecca, MD, PhD
Accepting new patients? Yes
Referrals required? From patients or physicians
Patient type treated: Older Adult

Adam Mecca, M.D., Ph.D. is an Assistant Professor of Psychiatry and the Associate Director of the Yale Alzheimer’s Disease Research Unit. He received his B.S. in Chemistry, Microbiology and Cell Science from the University of Florida in 2005 before matriculating to the UF M.D.-Ph.D. program from which he graduated in 2012. Dr. Mecca worked at the UF College of Medicine Equal Access Clinic for 10 years during undergraduate and graduate training. During that time, he helped advance the mission of the clinic and co-founded an international organization, Society of Student Run Free Clinics. After graduation, Dr. Mecca completed a residency in Psychiatry and a fellowship in Geriatric Psychiatry at Yale University. Dr. Mecca practices at the Yale Adler Geriatric Assessment center and is a faculty member in the Yale Department of Psychiatry. In his role as Associate Director of the Yale Alzheimer’s Disease Research Unit, Dr. Mecca works with a team to conduct clinical research testing potential therapies for Alzheimer’s disease. Another focus of his research is developing novel neuroimaging methods to investigate the neurobiology of Alzheimer’s disease. Recently, Dr. Mecca and his collaborators have used a novel positron emission tomography imaging technique to measure decreases in the number of connections between nerve cells in people with Alzheimer’s disease. They have also shown age and Alzheimer’s disease related declines in a specific synaptic receptor that is important for memory formation. The goal of this work is to develop a clearer understanding of Alzheimer’s disease to develop treatments.


Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.